Sintx Technologies (NASDAQ:SINT) Posts Earnings Results, Misses Expectations By $0.02 EPS

Sintx Technologies (NASDAQ:SINT) announced its quarterly earnings results on Tuesday. The company reported ($0.75) earnings per share for the quarter, missing the consensus estimate of ($0.73) by ($0.02), FiscalAI reports. Sintx Technologies had a negative net margin of 1,058.60% and a negative return on equity of 366.49%. The firm had revenue of $0.45 million for the quarter, compared to the consensus estimate of $0.46 million.

Sintx Technologies Stock Performance

Shares of NASDAQ SINT traded up $0.07 during midday trading on Tuesday, hitting $1.77. 2,419,937 shares of the stock traded hands, compared to its average volume of 39,529. The firm has a market capitalization of $7.65 million, a P/E ratio of -0.35 and a beta of 0.62. Sintx Technologies has a one year low of $1.40 and a one year high of $6.78. The firm has a 50-day moving average of $1.83 and a two-hundred day moving average of $2.39.

Institutional Trading of Sintx Technologies

An institutional investor recently raised its stake in Sintx Technologies stock. Geode Capital Management LLC raised its position in Sintx Technologies, Inc. (NASDAQ:SINT) by 33.5% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 15,339 shares of the company’s stock after acquiring an additional 3,848 shares during the quarter. Geode Capital Management LLC owned approximately 0.56% of Sintx Technologies worth $49,000 at the end of the most recent quarter. 18.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have commented on SINT. Weiss Ratings reiterated a “sell (e+)” rating on shares of Sintx Technologies in a research note on Friday, July 17th. HC Wainwright reiterated a “buy” rating and issued a $10.00 price objective on shares of Sintx Technologies in a report on Wednesday, May 20th. Finally, Maxim Group reissued a “buy” rating and issued a $6.00 target price on shares of Sintx Technologies in a research report on Thursday, June 4th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $9.33.

Sintx Technologies Company Profile

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.